Severity in schizophrenia patients receiving atypical antipsychotic medications

Atypical antipsychotic drugs are nowadays the mainstay of treatment of schizophrenia due to their lesser extrapyramidal symptoms (EPS) as adverse effects. However, these drugs have different profiles of adverse drug reactions (ADRs). Here, the objective of this study was to analyze the probability,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam Fatmi1j, Syed Meraj, Koul1, Rakesh, Suruchi, Prakash, Ayub, Sheenam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492911/
https://www.ncbi.nlm.nih.gov/pubmed/37701510
http://dx.doi.org/10.6026/973206300181154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492911/
https://www.ncbi.nlm.nih.gov/pubmed/37701510
http://dx.doi.org/10.6026/973206300181154

Ejemplares similares